Purchases and Sales Made in Q2 2023 in Eiger Bio Pharmaceuticals, Inc. (EIGR)
This table provides information about the institutional ownership of Eiger Bio Pharmaceuticals, Inc. (EIGR) during Q2 2023. The information is specifically focused on institutions that hold shares of Eiger BioPharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 11, 2023
Q2 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-396K- 84.67% |
$218K - $499K
|
71.7K
$124K
|
|
|
Aug 11, 2023
Q2 2023
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-408K- 51.84% |
$225K - $515K
|
379K
$656K
|
|
|
Aug 14, 2023
Q2 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-690K- 82.46% |
$380K - $870K
|
147K
$254K
|
|
|
Aug 11, 2023
Q2 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-1.87M- 66.62% |
$1.03M - $2.36M
|
937K
$1.62M
|